Camilla Soenderby
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Camilla Soenderby is currently Director at Affibody Medical AB, Non-Executive Director at F2G Ltd. since 2021, Director at BB Biotech AG since 2024, Independent Director at Abivax SA since 2024, and Independent Director at Inventiva SA starting in 2026.
Former roles include Head-Product Strategy Officer at Takeda Pharmaceutical Co., Ltd. from 2019 to 2020, Head-Global Product Strategy at Shire France SAS, General Manager at Schering-Plough Ltd. (Taiwan), and General Manager at AbbVie SAS (France).
Education includes undergraduate studies at the University of Copenhagen.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABIVAX SA -.--% | 28.02.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BB BIOTECH AG | Direktor/Vorstandsmitglied | 21.03.2024 |
| ABIVAX | Direktor/Vorstandsmitglied | 02.04.2024 |
| INVENTIVA | Direktor/Vorstandsmitglied | 30.06.2026 |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Direktor/Vorstandsmitglied | 15.09.2021 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.01.2020 |
Schering-Plough Ltd. (Taiwan)
Schering-Plough Ltd. (Taiwan) Medical DistributorsDistribution Services Sells and supplies pharmaceutical products | Corporate Officer/Principal | - |
AbbVie SAS (France)
AbbVie SAS (France) Medical DistributorsDistribution Services Engages in wholesale distribution of prescription drugs and proprietary drugs | Corporate Officer/Principal | - |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
BB Biotech AG
BB Biotech AG Financial ConglomeratesFinance Provides investment services for biotechnology sector | Finance |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Inventiva SA
Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Schering-Plough Ltd. (Taiwan)
Schering-Plough Ltd. (Taiwan) Medical DistributorsDistribution Services Sells and supplies pharmaceutical products | Distribution Services |
AbbVie SAS (France)
AbbVie SAS (France) Medical DistributorsDistribution Services Engages in wholesale distribution of prescription drugs and proprietary drugs | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen